What we are studying
The purpose of this research study is to determine whether an investigational drug, is safe and beneficial in delaying or altering the decline in memory and daily functioning when given to people with Alzheimer’s disease (AD). The U.S. Food and Drug Administration (FDA) has not approved the investigational drug for the treatment of AD and we do not know whether daily use can change the course of the disease.
Participants will receive up to $2500 for completing all study visits.
If they choose to participate in the add on study, they will receive an additional $775 if all visits are complete.